Inventor

Graham John Warrellow

Inventor

Northwood, GB

Overview

1992–2021

Patent span

Chemistry

Primary field (CPC C)

Patents· 57 as inventor

Public. Assignee & technology derived from the patent record. Each patent links to its LexDana page.

C07Dprimary

C07DHeterocyclic compounds38%

A61PSpecific therapeutic activity of chemical compounds or medicinal preparations34%

C07CAcyclic or carbocyclic compounds13%

A61KPreparations for medical, dental or toiletry purposes5%

C07KPeptides5%

G01NInvestigating or analysing materials by determining their chemical or physical properties2%

Y10STechnical subjects covered by former uspc cross-reference art collections [xracs] and digests1%

C07BGeneral methods of organic chemistry1%

C40BCombinatorial chemistry1%

PatentTitleYear

10,883,996Methods of identifying signaling modulators of the trimeric TNFa2021 10,775,385Treatment of autoimmune and inflammatory disorders with asymmetric TNF alpha trimers2020 10,705,094TNF receptor signaling modulator assay2020 8,399,483'Quinoxaline and quinoline derivatives as kinase inhibitors'2013 7,582,676'2-phenylpyran-4-one derivatives as selective COX-2 inhibitors'2009 6,953,798'Î²-alanine derivates'2005 6,911,451'Phenylalanine derivatives'2005 6,780,874'Enamine derivatives'2004 6,740,654'Squaric acid derivatives'2004 6,677,339'Phenylalanine derivatives'2004 6,610,700'Enamine derivatives'2003 6,555,562'Phenylalanine derivatives'2003 6,545,013'2,7-naphthyridine derivatives'2003 6,534,513'Phenylalkanoic acid derivatives'2003 6,521,626'Thiocarboxamide derivatives'2003 6,518,283'Squaric acid derivatives'2003 6,465,471'Cinnamic acid derivatives'2002 6,455,539'Squaric acid derivates'2002 6,403,608'3-Substituted isoquinolin-1-yl derivatives'2002 6,369,229'Pyridylalanine derivatives'2002 6,362,204'Phenylalanine derivatives'2002 6,348,463'Phenylalanine derivatives'2002 6,329,372'Phenylalanine derivatives'2001 6,329,362'Cinnamic acid derivatives'2001 6,319,922'Propanoic acid derivatives'2001 6,297,264'Trisubstituted phenyl derivatives and process for their preparation'2001 6,274,577'Benzodiazepines'2001 6,245,774'Tri-substituted phenyl or pyridine derivatives'2001 6,197,792'Tetra-substituted phenyl derivatives and processes for their preparation'2001 6,197,794'Phenylalanine derivatives'2001 6,110,945'Aromatic amine derivatives'2000 6,093,696'Tyrosine derivatives'2000 6,080,790'Tri-substituted phenyl derivatives and processes for their preparations'2000 6,077,854'Tri-substituted phenyl derivatives and processes for their preparation'2000 5,962,483'Trisubstituted phenyl derivatives and processes for their preparation'1999 5,962,492'2 cyclo(alkyl and alkenyl) phenyl-alkenylyl heteroaryl compounds and pharmaceutical compositions containing same'1999 5,891,896'Tri-substituted phenyl derivatives useful as PDE IV inhibitors'1999 5,866,593'Trisubstituted phenyl derivatives and processes for their preparation'1999 5,859,034'Tri-substituted phenyl compounds which have useful pharmaceutical activity'1999 5,798,373'Tri-substituted phenyl derivatives useful as PDE IV inhibitors'1998 5,786,354'Tri-substituted phenyl derivatives and processes for their preparation'1998 5,780,477'Trisubstituted phenyl derivatives and processes for their preparation'1998 5,780,478'Tetra-substituted phenyl derivatives'1998 5,776,958'Trisubstituted phenyl derivatives and processes for their preparation'1998 5,739,144'Trisubstituted phenyl derivatives'1998 5,723,460'Cyclo (alkyl and alkenyl) phenyl-alkenylyl heteroaryl compounds and pharmaceutical compositions containing same'1998 5,693,659'Substituted oxime derivatives and processes for their preparation'1997 5,693,642'Piperazine derivatives as 5-HT.sub.1A ligands'1997 5,674,880'Tri-substituted phenyl derivatives and processes for their preparation'1997 5,633,257'Cyclo(alkyl and alkenyl)phenyl-alkenylyl(aryl and heteroaryl)compounds and pharmaceutical compositions containing them'1997 5,622,977'Tri-substituted (aryl or heteroaryl) derivatives and pharmaceutical compositions containing the same'1997 5,608,070'Enantioselective process for the preparation of chiral triaryl derivatives and chiral intermediates for use therein'1997 5,580,888'Styryl derivatives as anti-inflammatory agents'1996 5,491,147'Tri-substituted phenyl derivatives and their use in pharmaceutical compositions and methods of treatment'1996 5,346,896'1-(aryl or heteroaryl)-4[.omega.-(aryl or heteroaryl).omega.-(aryl or heteroaryl)alkylene]piperazines'1994 5,177,078'Piperazine derivatives'1993 5,169,845'Piperazine derivatives'1992

Career & activity timeline

Assembled from patent assignee/location history and declaration credentials.

1992–1997Patents assigned to WYETH JOHN & BROTHER LTD (4)· patent assignee history

1992–1994Based in Stanmore, GB· patent location history

1996–2002Patents assigned to CELLTECH THERAPEUTICS LTD (34)· patent assignee history

1996–2005Based in Northwood, GB· patent location history

1997–1998Based in Northwood, NH, US· patent location history

1999Based in Middlesex, GB· patent location history

2002–2005Patents assigned to CELLTECH R&D LTD (13)· patent assignee history

2013Patents assigned to ALLEN DANIEL REES (1)· patent assignee history

2013–2021Based in Slough, GB· patent location history

2020–2021Patents assigned to UCB Biopharma SRL (3)· patent assignee history

Inventor activity

Assignee and location history derived from the patent record.

Assignees

Assignee	Patents	Span
CELLTECH THERAPEUTICS LTD	34	1996–2002
CELLTECH R&D LTD	13	2002–2005
WYETH JOHN & BROTHER LTD	4	1992–1997
UCB Biopharma SRL	3	2020–2021
ALLEN DANIEL REES	1	2013

Locations

Location	Patents	Span
Northwood, GB	38	1996–2005
Northwood, NH, US	9	1997–1998
Slough, GB	3	2013–2021
Stanmore, GB	3	1992–1994
Middlesex, GB	2	1999